AxoGen, Inc. (0HKD.L)
USD 15.78
(-0.88%)
USD 15.78
(-0.88%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13.32 Million USD | 36.58% |
| 2022 | -23.47 Million USD | -19.72% |
| 2021 | -20.88 Million USD | -6.04% |
| 2020 | -19.27 Million USD | 24.63% |
| 2019 | -26.21 Million USD | -33.24% |
| 2018 | -20.33 Million USD | -165.35% |
| 2017 | -7.41 Million USD | 3.86% |
| 2016 | -7.69 Million USD | 14.21% |
| 2015 | -8.99 Million USD | 6.33% |
| 2014 | -9.59 Million USD | -1.9% |
| 2013 | -9.41 Million USD | -26.22% |
| 2012 | -7.46 Million USD | -11.47% |
| 2011 | -6.56 Million USD | -266.11% |
| 2010 | -1.82 Million USD | -111.44% |
| 2009 | 15.97 Million USD | 1645.84% |
| 2008 | -1.03 Million USD | -32.92% |
| 2007 | -777.64 Thousand USD | -109.09% |
| 2006 | -371.91 Thousand USD | -21.35% |
| 2005 | -306.48 Thousand USD | -449.53% |
| 2004 | 87.68 Thousand USD | 113.02% |
| 2003 | -1.09 Million USD | 64.01% |
| 2002 | -1.86 Million USD | 72.73% |
| 2001 | -6.86 Million USD | -241.52% |
| 2000 | -2.49 Million USD | -101.02% |
| 1999 | -1.98 Million USD | -433.33% |
| 1998 | -900 Thousand USD | -90.91% |
| 1997 | 400 Thousand USD | 725.0% |
| 1996 | 400 Thousand USD | -50.0% |
| 1995 | 500 Thousand USD | -33.33% |
| 1994 | 900 Thousand USD | 20.0% |
| 1993 | 1.4 Million USD | -23.08% |
| 1992 | 1.2 Million USD | 18.18% |
| 1991 | 1.5 Million USD | 66.67% |
| 1990 | 900 Thousand USD | 0.0% |
| 1989 | 900 Thousand USD | -10.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.66 Million USD | -1124.37% |
| 2024 Q2 | 1.63 Million USD | 167.66% |
| 2023 Q4 | -1.34 Million USD | 48.88% |
| 2023 Q2 | -6.13 Million USD | 0.76% |
| 2023 Q3 | -2.62 Million USD | 57.22% |
| 2023 Q1 | -6.17 Million USD | -35.16% |
| 2023 FY | - USD | 36.58% |
| 2022 Q2 | -6.74 Million USD | 33.37% |
| 2022 Q3 | -3.63 Million USD | 46.09% |
| 2022 Q4 | -4.57 Million USD | -25.65% |
| 2022 Q1 | -10.12 Million USD | -131.32% |
| 2022 FY | - USD | -19.72% |
| 2021 Q3 | -5.53 Million USD | 9.86% |
| 2021 Q1 | -4.93 Million USD | -14.04% |
| 2021 FY | - USD | -6.04% |
| 2021 Q4 | -4.37 Million USD | 20.85% |
| 2021 Q2 | -6.13 Million USD | -24.44% |
| 2020 Q1 | -7.65 Million USD | -8.95% |
| 2020 FY | - USD | 24.63% |
| 2020 Q4 | -4.32 Million USD | -2882.07% |
| 2020 Q3 | -145 Thousand USD | 98.2% |
| 2020 Q2 | -8.07 Million USD | -5.42% |
| 2019 Q1 | -9.53 Million USD | -62.61% |
| 2019 FY | - USD | -33.24% |
| 2019 Q3 | -5.43 Million USD | 21.87% |
| 2019 Q4 | -7.03 Million USD | -29.39% |
| 2019 Q2 | -6.95 Million USD | 27.05% |
| 2018 Q3 | -4.61 Million USD | -3.34% |
| 2018 Q4 | -5.86 Million USD | -27.15% |
| 2018 FY | - USD | -165.35% |
| 2018 Q2 | -4.46 Million USD | 6.91% |
| 2018 Q1 | -4.79 Million USD | -164.45% |
| 2017 Q1 | -3.07 Million USD | -13.34% |
| 2017 Q2 | -1.33 Million USD | 56.74% |
| 2017 Q3 | -1.35 Million USD | -1.55% |
| 2017 FY | - USD | 3.86% |
| 2017 Q4 | -1.81 Million USD | -34.02% |
| 2016 Q2 | -1.5 Million USD | 41.04% |
| 2016 Q1 | -2.54 Million USD | 3.95% |
| 2016 FY | - USD | 14.21% |
| 2016 Q3 | -1.07 Million USD | 28.56% |
| 2016 Q4 | -2.71 Million USD | -153.15% |
| 2015 FY | - USD | 6.33% |
| 2015 Q4 | -2.65 Million USD | -44.18% |
| 2015 Q1 | -2.49 Million USD | 5.81% |
| 2015 Q2 | -2.07 Million USD | 16.6% |
| 2015 Q3 | -1.83 Million USD | 11.53% |
| 2014 Q1 | -2.95 Million USD | -8.16% |
| 2014 FY | - USD | -1.9% |
| 2014 Q4 | -2.64 Million USD | -51.46% |
| 2014 Q3 | -1.74 Million USD | 22.4% |
| 2014 Q2 | -2.25 Million USD | 23.71% |
| 2013 Q4 | -2.72 Million USD | -21.63% |
| 2013 Q2 | -2.15 Million USD | 5.65% |
| 2013 Q1 | -2.28 Million USD | -3.22% |
| 2013 FY | - USD | -26.22% |
| 2013 Q3 | -2.24 Million USD | -3.97% |
| 2012 Q4 | -2.21 Million USD | -21.94% |
| 2012 FY | - USD | -11.47% |
| 2012 Q3 | -1.81 Million USD | -20.66% |
| 2012 Q2 | -1.5 Million USD | 18.84% |
| 2012 Q1 | -1.85 Million USD | 5.64% |
| 2011 Q1 | 1.49 Million USD | 387.9% |
| 2011 Q2 | 517.3 Thousand USD | -65.33% |
| 2011 Q3 | -2.38 Million USD | -560.97% |
| 2011 FY | - USD | -266.11% |
| 2011 Q4 | -1.96 Million USD | 17.52% |
| 2010 Q3 | -607.74 Thousand USD | -82.54% |
| 2010 Q4 | -518.34 Thousand USD | 14.71% |
| 2010 FY | - USD | -111.44% |
| 2010 Q1 | -369.73 Thousand USD | -102.3% |
| 2010 Q2 | -332.94 Thousand USD | 9.95% |
| 2009 Q4 | 16.08 Million USD | 12873.21% |
| 2009 FY | - USD | 1645.84% |
| 2009 Q3 | -125.95 Thousand USD | -186.7% |
| 2009 Q1 | -128.65 Thousand USD | -10.73% |
| 2009 Q2 | 145.27 Thousand USD | 212.92% |
| 2008 FY | - USD | -32.92% |
| 2008 Q1 | -161.93 Thousand USD | -552.56% |
| 2008 Q4 | -116.18 Thousand USD | 79.97% |
| 2008 Q3 | -580.01 Thousand USD | -230.43% |
| 2008 Q2 | -175.53 Thousand USD | -8.4% |
| 2007 FY | - USD | -109.09% |
| 2007 Q4 | -24.81 Thousand USD | 94.65% |
| 2007 Q3 | -463.66 Thousand USD | -179.61% |
| 2007 Q2 | -165.82 Thousand USD | -34.43% |
| 2007 Q1 | -123.34 Thousand USD | 28.16% |
| 2006 Q3 | -55.7 Thousand USD | 44.12% |
| 2006 Q2 | -99.68 Thousand USD | -122.33% |
| 2006 Q1 | -44.83 Thousand USD | -131.02% |
| 2006 FY | - USD | -21.35% |
| 2006 Q4 | -171.7 Thousand USD | -208.26% |
| 2005 FY | - USD | -449.53% |
| 2005 Q3 | -14.95 Thousand USD | 75.94% |
| 2005 Q2 | -62.14 Thousand USD | 83.38% |
| 2005 Q1 | -373.88 Thousand USD | -299.67% |
| 2005 Q4 | 144.51 Thousand USD | 1066.43% |
| 2004 Q4 | 187.25 Thousand USD | 259.38% |
| 2004 Q1 | 170.67 Thousand USD | 361.49% |
| 2004 Q2 | 80.23 Thousand USD | -52.99% |
| 2004 FY | - USD | 113.02% |
| 2004 Q3 | -117.48 Thousand USD | -246.42% |
| 2003 Q1 | -152.39 Thousand USD | 79.42% |
| 2003 Q2 | -294.07 Thousand USD | -186.33% |
| 2003 Q4 | -62.67 Thousand USD | 69.27% |
| 2003 FY | - USD | 64.01% |
| 2003 Q3 | 51.15 Thousand USD | 27.64% |
| 2002 Q1 | -610.97 Thousand USD | 0.0% |
| 2002 Q4 | -496.64 Thousand USD | -155.25% |
| 2002 Q3 | -192.1 Thousand USD | 65.6% |
| 2002 Q2 | -567.01 Thousand USD | 7.16% |
| 2002 FY | - USD | 72.73% |
| 2001 FY | - USD | -241.52% |
| 2001 Q3 | -1.08 Million USD | 81.87% |
| 2001 Q2 | -1.67 Million USD | -1494.01% |
| 2001 Q1 | -373.75 Thousand USD | 19.66% |
| 2000 Q2 | -628.38 Thousand USD | -50.16% |
| 2000 FY | - USD | -101.02% |
| 2000 Q1 | -429.85 Thousand USD | 15.25% |
| 2000 Q3 | -398.54 Thousand USD | 37.72% |
| 2000 Q4 | -999.33 Thousand USD | -17.4% |
| 1999 Q1 | -200 Thousand USD | 50.0% |
| 1999 FY | - USD | -433.33% |
| 1999 Q4 | -500 Thousand USD | 0.0% |
| 1999 Q3 | -500 Thousand USD | -150.0% |
| 1999 Q2 | -200 Thousand USD | 0.0% |
| 1998 Q1 | -100 Thousand USD | -200.0% |
| 1998 Q3 | - USD | 300.0% |
| 1998 Q4 | -400 Thousand USD | -300.0% |
| 1998 FY | - USD | -90.91% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q2 | 400 Thousand USD | -52.63% |
| 1997 Q4 | 100 Thousand USD | -75.0% |
| 1997 FY | - USD | 725.0% |
| 1997 Q1 | 1.9 Million USD | 2000.0% |
| 1997 Q3 | 400 Thousand USD | -55.56% |
| 1996 Q4 | - USD | -133.33% |
| 1996 Q2 | 300 Thousand USD | -40.0% |
| 1996 FY | - USD | -50.0% |
| 1996 Q1 | 500 Thousand USD | 200.0% |
| 1996 Q3 | 300 Thousand USD | 0.0% |
| 1995 Q2 | -100 Thousand USD | -120.0% |
| 1995 Q4 | -500 Thousand USD | -266.67% |
| 1995 FY | - USD | -33.33% |
| 1995 Q3 | 300 Thousand USD | 400.0% |
| 1995 Q1 | 500 Thousand USD | 150.0% |
| 1994 Q4 | 200 Thousand USD | 0.0% |
| 1994 FY | - USD | 20.0% |
| 1994 Q1 | 300 Thousand USD | 0.0% |
| 1994 Q2 | 200 Thousand USD | -33.33% |
| 1994 Q3 | 200 Thousand USD | 0.0% |
| 1993 Q2 | 400 Thousand USD | 100.0% |
| 1993 Q1 | 300 Thousand USD | 100.0% |
| 1993 FY | - USD | -23.08% |
| 1993 Q4 | 300 Thousand USD | -50.0% |
| 1993 Q3 | 600 Thousand USD | 50.0% |
| 1992 Q1 | 400 Thousand USD | 0.0% |
| 1992 Q2 | 300 Thousand USD | -25.0% |
| 1992 Q3 | 400 Thousand USD | 33.33% |
| 1992 Q4 | 100 Thousand USD | -75.0% |
| 1992 FY | - USD | 18.18% |
| 1991 Q1 | 200 Thousand USD | -33.33% |
| 1991 Q4 | 400 Thousand USD | 0.0% |
| 1991 Q3 | 400 Thousand USD | 33.33% |
| 1991 FY | - USD | 22.22% |
| 1991 Q2 | 400 Thousand USD | 50.0% |
| 1990 FY | - USD | 28.57% |
| 1990 Q3 | 400 Thousand USD | 110.34% |
| 1990 Q4 | 300 Thousand USD | 0.0% |
| 1990 Q1 | 2.2 Million USD | 60.0% |
| 1990 Q2 | -2.9 Million USD | -220.83% |
| 1989 Q1 | 1.6 Million USD | -5.88% |
| 1989 Q4 | 1.5 Million USD | 400.0% |
| 1989 FY | - USD | -30.0% |
| 1989 Q3 | 300 Thousand USD | 107.32% |
| 1989 Q2 | -4.1 Million USD | -356.25% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 87.053% |
| Accuray Incorporated | 9 Million USD | 247.941% |
| Align Technology, Inc. | 799.03 Million USD | 101.668% |
| Elevance Health Inc. | 10.49 Billion USD | 100.127% |
| Boston Scientific Corporation | 3.61 Billion USD | 100.369% |
| CVS Health Corporation | 18.17 Billion USD | 100.073% |
| Cardinal Health, Inc. | 1.97 Billion USD | 100.674% |
| Centene Corporation | -463 Million USD | 97.121% |
| DaVita Inc. | 2.34 Billion USD | 100.568% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 100.105% |
| Hologic, Inc. | 1.29 Billion USD | 101.028% |
| Humana Inc. | -561 Million USD | 97.624% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 101.095% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 100.988% |
| Masimo Corporation | 236.7 Million USD | 105.631% |
| McKesson Corporation | 4.66 Billion USD | 100.286% |
| Patterson Companies, Inc. | 374.75 Million USD | 103.556% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 100.77% |
| ResMed Inc. | 1.6 Billion USD | 100.833% |
| Henry Schein, Inc. | 943 Million USD | 101.413% |
| Teladoc Health, Inc. | 153.99 Million USD | 108.655% |
| Universal Health Services, Inc. | 1.74 Billion USD | 100.764% |
| Veeva Systems Inc. | 429.33 Million USD | 103.104% |
| Baxter International Inc. | 2.77 Billion USD | 100.48% |
| Becton, Dickinson and Company | 4.27 Billion USD | 100.312% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.557% |
| Danaher Corporation | 7.49 Billion USD | 100.178% |
| Stryker Corporation | 5.16 Billion USD | 100.258% |
| Medtronic plc | 9.05 Billion USD | 100.147% |